Skip to main content
Terug
PHPRF logo

Primary Health Properties PLC

Datakwaliteit: 100%
Oversold
PHPRF
OTC Real Estate REIT - Healthcare Facilities
€ 1,24
€ 0,00 (0,00%)
Marktkapitalisatie: 1,66B
Dagbereik
€ 1,24 € 1,45
52-Weeksbereik
€ 1,20 € 1,45
Volume
100
50D / 200D Gem.
€ 1,40 / € 1,31
Vorige Slotkoers
€ 1,24

Koershistorie

Financiële Trends

Sectorvergelijking

vs Real Estate sector mediaan (361 peers)

Metriek Aandeel Sector Mediaan
P/E 13,9 11,2
P/B 0,7 0,8
ROE % 6,1 6,1
Net Margin % 46,0 19,9
Rev Growth 5Y % 15,5 6,9
D/E 1,3 0,9

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 0,08
€ 0,07 – € 0,09
 340 M 1
FY2029 € 0,08
€ 0,07 – € 0,09
 320 M 1
FY2028 € 0,08
€ 0,07 – € 0,09
 320 M 1

Belangrijkste Punten

Revenue grew 15,48% annually over 5 years — strong growth
Earnings grew 187,39% over the past year
Net margin of 45,95% shows strong profitability
Negative free cash flow of 0,0
P/E of 13,93 — trading at a low valuation
PEG of 0,17 suggests growth is underpriced

Groei

Revenue Growth (5Y)
15,48%
Revenue (1Y)176,07%
Earnings (1Y)187,39%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
6,06%
ROIC2,58%
Net Margin45,95%
Op. Margin77,99%

Veiligheid

Debt / Equity
1,29
Current Ratio6,67
Interest Coverage2,38

Waardering

P/E Ratio
13,93
P/B Ratio0,65
EV/EBITDA24,48
Dividend Yield0,05%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 176,07% Revenue Growth (3Y) 23,49%
Earnings Growth (1Y) 187,39% Earnings Growth (3Y) 108,76%
Revenue Growth (5Y) 15,48% Earnings Growth (5Y) -4,00%
Profitability
Revenue (TTM) 258,96M Net Income (TTM) 118,98M
ROE 6,06% ROA 1,97%
Gross Margin 89,58% Operating Margin 77,99%
Net Margin 45,95% Free Cash Flow (TTM) 0,0
ROIC 2,58% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,29 Current Ratio 6,67
Interest Coverage 2,38 Dividend Yield 0,05%
Valuation
P/E Ratio 13,93 P/B Ratio 0,65
P/S Ratio 6,40 PEG Ratio 0,17
EV/EBITDA 24,48 Dividend Yield 0,05%
Market Cap 1,66B Enterprise Value 4,94B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 258,96M 93,80M 169,80M 154,10M 145,60M
Net Income 118,98M 41,40M 27,30M 56,30M 140,10M
EPS (Diluted) 0,07 0,03 0,02 0,02 0,10
Gross Profit 231,96M 93,80M 151,00M 141,50M 136,70M
Operating Income 201,97M 47,00M 84,30M 70,40M 236,70M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6,04B 2,79B 2,83B 2,86B 2,85B
Total Liabilities 3,48B 1,42B 1,40B 1,38B 1,35B
Shareholders' Equity 2,55B 1,38B 1,42B 1,48B 1,50B
Total Debt 3,31B 1,34B 1,33B 1,30B 1,28B
Cash & Equivalents 20,00M 3,50M 3,20M 29,10M 33,40M
Current Assets 59,99M 3,50M 40,00M 40,90M 45,60M
Current Liabilities 9,00M 213,70M 41,50M 3,30M 40,00M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Capital Heavy Grower
#27 of 75
65
Growth + Value Growth at a Reasonable Price (Peter Lynch)
#70 of 326
65

Recente Activiteit

Ingestapt Capital Heavy Grower
Mar 24, 2026
Ingestapt Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026